Revvity, Inc. operates primarily through two business segments: Life Sciences and Diagnostics, which contribute roughly equally to its total revenue. The Life Sciences segment provides reagents, instruments, and informatics software that support drug discovery, cellular research, and genomic workflows for academic and biopharmaceutical customers. The Diagnostics segment delivers specialized testing solutions, including immunodiagnostics, reproductive health screening, and infectious disease testing for clinical laboratories and public health authorities. Headquartered in Waltham, Massachusetts, the company serves a global customer base across the Americas, Europe, and Asia. Revvity was formed following the strategic carve-out of PerkinElmer's applied markets division, allowing the remaining public entity to focus entirely on high-growth health sciences.
